Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Paciocco

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|December 11, 2022
Left Heart Disease Phenotype in Elderly Patients with Pulmonary Arterial Hypertension: Insights from the Italian PATRIARCA RegistryMatteo Toma, Roberta Miceli, Edoardo Bonsante, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertensionMichele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, et al.
Internal and Emergency Medicine|September 16, 2023
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective studyPaola Faverio, Giuseppe Paciocco, Elena Tassistro, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 23, 2016
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trialPatrizio Vitulo, Anna Stanziola, Marco Confalonieri, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Respiratory Research|September 3, 2022
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approachPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2024
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertensionStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
European Heart Journal|February 6, 2026
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-upStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|December 11, 2022
Left Heart Disease Phenotype in Elderly Patients with Pulmonary Arterial Hypertension: Insights from the Italian PATRIARCA RegistryMatteo Toma, Roberta Miceli, Edoardo Bonsante, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 16, 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertensionMichele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, et al.
Internal and Emergency Medicine|September 16, 2023
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective studyPaola Faverio, Giuseppe Paciocco, Elena Tassistro, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 23, 2016
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trialPatrizio Vitulo, Anna Stanziola, Marco Confalonieri, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Respiratory Research|September 3, 2022
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approachPaola Faverio, Alessia Fumagalli, Sara Conti, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2024
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertensionStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
European Heart Journal|February 6, 2026
Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-upStefano Ghio, Roberto Badagliacca, Michele D'Alto, et al.
Pageof 3